Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Scopus by Title (Ref)

1. A Real-World Retrospective Cohort Study on the Clinical Effect of Silymarin (Legalon) on Liver Damage and Diseases Using a Domestic Multicenter Common Data Model

- Jang B.K. , et al.

2. Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury

- Shahsavari K. , et al.

3. Expert consensus on the off-label clinical use of glucose-lowering medications (2025 edition)

- Feng B. , et al.

4. Silymarin for adults with metabolic dysfunction-associated steatotic liver disease

- Wang C. , et al.

5. Efficacy of Hypoglycemic Agents in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A Systematic Review and Network Meta-Analysis

- Ren Q. , et al.

6. Lactobacillus rhamnosus GG Combined with Metformin Alleviates Alcohol-Induced Liver Inflammation in Mice by Maintaining the Intestinal Barrier and Regulating Treg/Th1 Cells

- Zhu Y. , et al.

7. Effects of silymarin supplementation in late pregnancy and lactation on reproductive performance, colostrum quality, blood biochemistry and inflammation levels of sows

- Cong G. , et al.

8. Effects of silymarin on insulin resistance and sensitivity: A systematic review and meta-analysis of randomized controlled trials

- Yin S. , et al.

9. Effects of Silybum marianum, Pueraria lobate, combined with Salvia miltiorrhiza tablets on non-alcoholic fatty liver disease in adults: A triple-blind, randomized, placebo-controlled clinical trial

- Li B.y. , et al.

10. Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD

- Ezhilarasan D. , et al.

11. Effects of different natural products in patients with non-alcoholic fatty liver disease—A network meta-analysis of randomized controlled trials

- Liu H. , et al.

12. Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta-analysis of randomized controlled trials

- Wang H. , et al.

13. Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis

- Malik A. , et al.

14. The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review

- Zachou M. , et al.

15. Evidence-Based Herbal Treatments in Liver Diseases

- Karakus M.M. , et al.

16. Benefits of Combining Sonchus brachyotus DC. Extracts and Synbiotics in Alleviating Non-Alcoholic Fatty Liver Disease

- Huang W. , et al.

17. Comparison of efficacy of anti-diabetics on non-diabetic NAFLD: A network meta-analysis

- Jin D. , et al.

18. Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials

- Wang Z. , et al.

19. Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study

- Jianfang F. , et al.

20. Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,

- Zou C.y. , et al.

21. Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review

- Nucera S. , et al.

22. Silybin induces endothelium-dependent vasodilation via TRPV4 channels in mouse mesenteric arteries

- Wen X. , et al.

23. Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial

- Khoshbaten M. , et al.

24. Silymarin Modulates Microbiota in the Gut to Improve the Health of Sow from Late Gestation to Lactation

- Xu S. , et al.

25. Mechanistic Insights into the Pharmacological Significance of Silymarin

- Wadhwa K. , et al.